No Data
Is Boai NKY Medical Holdings (SZSE:300109) Using Too Much Debt?
Boai NKY Medical (300109.SZ): The construction project for the annual production of 0.012 million tons of the new PVP polymerization unit has been initiated.
On December 23, Gelonghui reported that Boai NKY Medical (300109.SZ) stated on the investor interaction platform that the company's PVP annual production capacity is 0.02 million tons. To expedite the digestion of the old and new NVP monomer production lines totaling 0.035 million tons, the company has initiated a construction project for a new PVP polymerization unit with an annual output of 0.012 million tons. A certain increase is expected in the New energy Fund industry in 2025.
Boai NKY Medical (300109.SZ): Currently, there are no PEEK products.
Gelonghui reported on December 23 that Boai NKY Medical (300109.SZ) stated on the investor interaction platform that the company currently does not have PEEK products.
Boai NKY Medical (300109.SZ): Related Shareholders have terminated their joint action agreement and changed the actual controller.
On December 16, Glonghui reported that Boai NKY Medical (300109.SZ) announced that it recently received a notice from the company's controlling shareholder and one of the actual controllers, Mr. Ren Dalong. He, along with Mr. Wang Donghu, Mr. Yang Haijiang, Mr. Zhang Junzheng, and Mr. Yang Hongbo, decided through amicable consultation to terminate the "Joint Action Agreement" signed with Wang Donghu and Yang Haijiang on December 20, 2023. The period of joint action will be from December 21, 2023, to December 20, 2024. At the same time, they will also terminate the "Joint Action Agreement" signed with Wang Donghu, Yang Haijiang, Zhang Junzheng, and Yang Hongbo on February 18, 2024.
The Market Lifts Boai NKY Medical Holdings Ltd. (SZSE:300109) Shares 28% But It Can Do More
Boai Nky Medical (300109.SZ): The company currently has an aggregate capacity of 0.034 million tons of nvp and 0.02 million tons of pvp.
On November 28, Gelonghui reported that boai nky medical (300109.SZ) indicated on the investor interaction platform that the company currently has an aggregate capacity of 0.034 million tons of NVP and 0.02 million tons of PVP. In the future, based on market sales and the expansion of product applications, the company will timely adjust the NVP monomer capacity and PVP aggregation capabilities.
